Completed
Allergen Challenge Chamber Study With Single Dose Intranasal GSK1004723 Compared With Placebo
NCT00824356
- Conditions
- Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
- Locations
-
- GSK Investigational Site Hanover, Lower Saxony, Germany